MedTrace Logo

Down Syndrome and Continuous Positive Pressure Therapy

NCT00394290 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2019-03-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and tolerability of Continuous Positive Pressure for SAOS in Down Syndrome patients.

Conditions

  • Down Syndrome
  • Obstructive Sleep Apnea Syndrome

Interventions

DEVICE

Continuous Positive Pressure

Nighttime continuous positive pressure device, to be used every day

Sponsors & Collaborators

  • Fondation Jérôme Lejeune

    collaborator OTHER

  • Institut Jerome Lejeune

    lead OTHER

Principal Investigators

  • Martine Conte, M.D. · Institut Jerome Lejeune

  • Franck STURTZ, M.D. · Institut Jerome Lejeune

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-16
Primary Completion
2012-10-31
Completion
2012-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00394290 on ClinicalTrials.gov